# STRATEGY_NOTE — Cycle 18 / Portfolio Hardening Phase 6

_Date: 2026-06-14 · Scope: T21–T22_

## Recommendation

Pause before Phase 7 packaging.

Phase 6 keeps the public posture bounded to local/pilot evidence and does not
claim production readiness. The new deployment-readiness notes are useful, but
the review found runtime/config and evidence-state drift that would make the
next one-page case study brittle if left open.

## Strategic Findings

| ID | Severity | Finding | Recommended Action |
|----|----------|---------|--------------------|
| STRAT-18-1 | P1 | The local Compose readiness path is not yet trustworthy enough for hiring packaging. | Fix Compose migration/health/env behavior before T23. |
| STRAT-18-2 | P2 | README and task graph still contain stale claims around the CI eval gate and old phase statuses. | Align public evidence state before building the case study. |
| STRAT-18-3 | P2 | Architecture remains a primary proof path, but still carries known security/readiness drift. | Refresh architecture/spec wording in the Phase 6 fix packet. |
| STRAT-18-4 | P3 | `.env.example` has small consistency defects that make the readiness notes look less practiced. | Normalize examples and add a test or grep guard. |

## Overclaim Review

No broad production-readiness overclaim was found. The main risk is narrower:
public docs imply repeatable local readiness while Compose/env details still
have execution defects.

## Next Action

Run a Phase 6 remediation packet before `T23`.
